Business Context and Reporting Period
Rand Capital Corporation (Rand) is a publicly traded Business Development Company (BDC) and operates a wholly-owned Small Business Investment Company (SBIC) subsidiary licensed by the U.S. Small Business Administration (SBA). The company invests in a portfolio of private companies through debt and equity instruments. This Form 10-Q covers the quarter ended March 31, 2010.
Key Financial Metrics
| Metric | Q1 2010 | Q1 2009 |
|---|---|---|
| Total Assets | $34,215,421 | $35,631,371 |
| Investments at Fair Value | $24,554,236 | $24,296,145 |
| Cash and Cash Equivalents | $7,560,176 | $1,967,663 |
| Total Liabilities | $11,688,805 | $12,425,490 |
| SBA Debentures | $10,000,000 | $9,100,000 |
| Net Assets | $22,526,616 | $23,205,881 |
| Net Asset Value (NAV) per Share | $3.30 | $3.40 |
| Investment Income | $188,386 | $378,259 |
| Total Expenses | $427,228 | $409,448 |
| Net Investment Loss | $(159,389) | $(21,239) |
| Net Decrease in Net Assets from Operations | $(679,265) | $(21,239) |
| Net Cash Used in Operating Activities | $(1,714,699) | $(724,589) |
Material Changes vs. Prior Period
- Portfolio Valuation: Investments at fair value increased by $258,091 (1.1%) to $24.55 million. However, this was offset by a significant $800,000 decrease in unrealized appreciation due to a valuation write-down of the Innov-X Systems, Inc. (Innovex) equity holding.
- Investment Income: Total investment income dropped 50.2% to $188,386. While interest from portfolio companies rose 22.9% to $166,497 due to new debentures, dividend income plummeted 93.8% to $13,902 as a large distribution from Gemcor II, LLC in the prior year did not recur.
- Liquidity: Cash and cash equivalents increased significantly to $7.56 million (34% of net assets) from $1.97 million in Q1 2009, driven by a $900,000 drawdown on SBA debentures and lower investment outflows relative to the prior year.
- Debt: SBA debentures increased by $900,000 to $10 million as the company drew down remaining leverage capacity.
Outlook, Risks, and Management Commentary
- Investment Activity: The company originated $1.055 million in new investments during the quarter, including stakes in GridApp Systems, Rheonix, Niagara Dispensing, and Microcision. A subsequent investment of $225,000 was made after the quarter-end.
- Valuation Risk: The $800,000 unrealized loss on Innovex was attributed to an updated evaluation of the M&A market for similar companies. Management notes that 99% of the portfolio consists of restricted securities (Level 3 assets), making valuations subjective and dependent on management judgment.
- Interest Accruals: The company ceased accruing interest on several portfolio companies (APF, Associates Interactive, Golden Goal, G-Tec, UStec, WineIsIt) due to doubts regarding collectability or default status.
- Liquidity Outlook: Management expects current cash levels and scheduled portfolio payments to be sufficient to meet needs throughout 2010. The company is evaluating potential exits to increase liquidity for new investments.
- Risk Factors: Results are subject to volatility due to the timing of realized/unrealized gains, competition faced by portfolio companies, and general economic conditions. There is no guarantee that portfolio companies will have sufficient capital to remain viable.
Investor Verification Checklist
- Valuation Methodology: Verify the assumptions used for the $800,000 write-down of Innov-X Systems and the fair value of other Level 3 assets, which represent the vast majority of the portfolio.
- Interest Accrual Status: Review the specific financial health of portfolio companies where interest accrual has ceased (e.g., APF, Golden Goal) to assess potential credit losses.
- Dividend Sustainability: Confirm the volatility of dividend income, which dropped significantly from the prior year, and assess reliance on interest income versus capital appreciation.
- Debt Service: Monitor the company's ability to service the $10 million SBA debenture obligation, particularly given the net investment loss for the quarter.
- Concentration Risk: Note that Gemcor II, Innov-X, and Synacor represent 25%, 22%, and 17% of the portfolio fair value, respectively, creating significant concentration risk.